関連する実験動画
Updated: Jul 16, 2026

13:58
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Published on: October 22, 2012
クルーツフェルト・ヤコブ病変体におけるMHC型化
Mark B Pepys1, Alison Bybee, David R Booth
1Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Rowland Hill Street, NW3 2PF, London, UK. m.pepys@rfc.ucl.ac.uk
Lancet (London, England)
|February 14, 2003
まとめ
メジャー・ヒストコンパティビリティ・コンプレックス (MHC) タイプは,変異型クレッツフェルト・ヤコブ病 (vCJD) の感受性や臨床表現に影響を与えない. この研究では,MHC遺伝子型とvCJD発症または持続期間との間に有意な関連性が見つかりませんでした.
科学分野:
- 神経科学は神経科学である.
- 免疫遺伝学 免疫遺伝学とは
- プリオン病はプリオン病である.
背景:
- 変異型クレッツフェルト・ヤコブ病 (vCJD) は致命的な神経変性疾患である.
- vCJDの感受性および疾患進行に影響を与える要因を理解することは,管理に極めて重要です.
- メジャー・ヒストコンパティビリティ・コンプレックス (MHC) は,免疫反応と疾患の感受性において重要な役割を果たします.
研究 の 目的:
- MHCのゲノタイプとvCJDの感受性との潜在的な関連性を調査する.
- MHCのフェノタイプがvCJDの臨床表現と相関するかどうかを判断し,発症年齢と疾患の持続時間を含む.
主な方法:
- vCJDと診断された76人のMHCロシの遺伝子型決定.
- vCJD患者と131人の健康な対照群のMHC遺伝子型頻度の比較.
- vCJDの発症年齢と症状の発現から死亡までの期間に関連してMHCのフェノタイプの分析.
主要な成果:
- vCJDと対照群のいずれかのMHCタイプの頻度において,有意な差異は観察されなかった.
- 特定のMHC型とvCJDの発症年齢との関連は見つかりませんでした.
- MHC型は,発症から死亡までのvCJDの持続時間と相関しませんでした.
結論:
- これらの発見は,VCJDの発症に対する感受性の決定において,MHCタイプが果たす役割を支持するものではありません.
- MHCのゲノタイプは,クレッツフェルト・ヤコブ病変体の臨床表現や進行に影響を与えないようです.
- vCJDに影響を与える他の遺伝的または環境的要因を特定するために,さらなる研究が必要になる可能性があります.
さらに関連する動画
関連する概念動画
Multiple Allele Traits
The Concept of Multiple Allelism
Mismatch Repair
Overview
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

